Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Humanigen plans 1:5 reverse stock split ahead of potential uplisting to Nasdaq exchange

% of readers think this story is Fact. Add your two cents.


Humanigen Inc (OTCMKTS:HGEN), the biotech focused on cancers and infectious diseases, is poised to carry out a reverse share split ahead of a potential listing on the Nasdaq exchange.

In a statement, the firm said its board had decided to carry out a 1:5 (every five shares consolidated into one) reverse split of its outstanding shares, reducing the number of shares to around 42 million, from 211 million previously.

READ: Humanigen says lenzilumab demonstrated 80% reduction in relative risk of invasive mechanical ventilation and/or death in coronavirus patients

The split is expected to occur at 4:30pm EST on September 11 this year, with trading expected to begin on the split-adjusted basis on the OTCQB venture market at the market open on September 14.

The stock will continue to trade under the symbol ‘HGEN’ but the security will be assigned a new CUSIP number, the group told investors.

The move is “intended to enable the company to achieve several important corporate objectives”, the company said, including satisfying the minimum bid price requirement in connection with the company’s application to list on the Nasdaq and making additional shares of common stock available for future issue.

Last week, the company revealed that the first case-control data of lenzilumab in severe coronavirus (COVID-19) cases showed an 80% reduction in relative risk of invasive mechanical ventilation (IMV) and/or death for patients treated with the drug compared to a matched control group.

Lenzilumab, an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody drug candidate, is being evaluated in an ongoing Phase III trial and was selected by the National Institutes of Health for its COVID-19 Big Effect Trial.

Contact the author at [email protected]

Story by ProactiveInvestors


Source: https://www.proactiveinvestors.com/companies/news/928415/humanigen-plans-15-reverse-stock-split-ahead-of-potential-uplisting-to-nasdaq-exchange-928415.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)

Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen!

Nascent Iodine - Promotes detoxification, mental focus and thyroid health.

Smart Meter Cover -  Reduces Smart Meter radiation by 96%! (See Video).

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.